SCHEMBL9997966

SCHEMBL9997966

CCCCCCCc1ccc(/C=C/COC(C)=O)cc1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ TNNC1 P63316 1/20 0.48
▸ THRB P10828 7/20 0.47
▸ THRA P10827 6/20 0.47
▸ MEN1 O00255 1/20 0.47
▸ KMT2A Q03164 1/20 0.47
▸ ALDH1A1 P00352 2/20 0.45
▸ ESR1 P03372 2/20 0.45
▸ ADRA2A P08913 2/20 0.45
▸ ADORA3 P0DMS8 2/20 0.45
▸ TACR2 P21452 2/20 0.45
▸ SLC6A2 P23975 2/20 0.45
▸ SLC6A4 P31645 2/20 0.45
▸ SLC6A3 Q01959 2/20 0.45
▸ KDM4E B2RXH2 1/20 0.45
▸ LMNA P02545 1/20 0.45
▸ SHBG P04278 1/20 0.45
▸ TP53 P04637 1/20 0.45
▸ CYP3A4 P08684 1/20 0.45
▸ HSPD1 P10809 1/20 0.45
▸ ADRB3 P13945 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9998003 1.00 TNNC1 (0.48) TNNC1THRBTHRAMEN1KMT2A
SCHEMBL9998123 1.00 TNNC1 (0.48) TNNC1THRBTHRAMEN1KMT2A
SCHEMBL9998272 1.00 TNNC1 (0.48) TNNC1THRBTHRAMEN1KMT2A
SCHEMBL9997698 1.00 TNNC1 (0.48) TNNC1THRBTHRAMEN1KMT2A
SCHEMBL9997695 1.00 TNNC1 (0.48) TNNC1THRBTHRAMEN1KMT2A
SCHEMBL9998273 1.00 TNNC1 (0.48) TNNC1THRBTHRAMEN1KMT2A
SCHEMBL9997968 1.00 TNNC1 (0.48) TNNC1THRBTHRAMEN1KMT2A
SCHEMBL9998121 1.00 TNNC1 (0.48) TNNC1THRBTHRAMEN1KMT2A
SCHEMBL9998473 0.99 THRB (0.47) TNNC1THRBTHRAMEN1KMT2A
SCHEMBL9998474 0.99 THRB (0.47) TNNC1THRBTHRAMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8558012-B2 2-fluoro-1,3-benzodithiol 1,1,3,3-tetraoxide derivative, production method thereof, and production method of monofluoromethyl group-containing compound using the same NAGOYA INSTITUTE OF TECHNOLOGY (JP) 2013-10-15 — — US disclosed
US-20110319637-A1 2-FLUORO-1,3-BENZODITHIOL 1,1,3,3-TETRAOXIDE DERIVATIVE, PRODUCTION METHOD THEREOF, AND PRODUCTION METHOD OF MONOFLUOROMETHYL GROUP-CONTAINING COMPOUND USING THE SAME NAGOYA INSTITUTE OF TECHNOLOGY (JP) 2011-12-29 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110319637-A1 2-FLUORO-1,3-BENZODITHIOL 1,1,3,3-TETRAOXIDE DERIVATIVE, PRODUCTION METHOD THEREOF, AND PRODUCTION METHOD OF MONOFLUOROMETHYL GROUP-CONTAINING COMPOUND USING THE SAME CBR1, CYP1B1, CYP2F1 TNNC1 4608/4885THRB 926/4885THRA 1085/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback